Skip to main content
. 2014 Sep;103(3):174–182. doi: 10.5935/abc.20140110

Table 6.

Medication in use at the final follow-up

ASA 424 (69.6%)
Clopidogrel 147 (24.4%)
ASA + clopidogrel 138 (22.5%)
Statin 420 (71.6%)
Beta-blocker 292 (4.6%)
ACE inhibitor 200 (33.2%)
AT2 receptor antagonists 94 (15.6%)
Nitrate 102 (16.9%)

ASA: acetylsalicylic acid ; ACE: angiotensin-converting enzyme inhibitors